
Imunon, Inc. – NASDAQ:CLSN
Imunon stock price today
Imunon stock price monthly change
Imunon stock price quarterly change
Imunon stock price yearly change
Imunon key metrics
Market Cap | 14.47M |
Enterprise value | N/A |
P/E | -0.49 |
EV/Sales | -17.84 |
EV/EBITDA | 0.32 |
Price/Sales | 36.24 |
Price/Book | 0.28 |
PEG ratio | N/A |
EPS | -2.02 |
Revenue | N/A |
EBITDA | -19.07M |
Income | -18.85M |
Revenue Q/Q | N/A |
Revenue Y/Y | 1780.19% |
Profit margin | -6973.1% |
Oper. margin | -5966.05% |
Gross margin | 0% |
EBIT margin | -5966.05% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeImunon stock price history
Imunon stock forecast
Imunon financial statements
Jun 2023 | 0 | -5.55M | |
---|---|---|---|
Sep 2023 | 0 | -3.47M | |
Dec 2023 | 7.05M | -4.88M | -69.33% |
Mar 2024 | 0 | -4.92M |
2022-05-16 | -0.99 | -1.82 |
---|---|---|
2022-08-15 | -1.12 | -0.87 |
Jun 2023 | 28721694 | 7.20M | 25.09% |
---|---|---|---|
Sep 2023 | 24654428 | 6.58M | 26.7% |
Dec 2023 | 21918069 | 8.53M | 38.92% |
Mar 2024 | 14324768 | 5.82M | 40.66% |
Jun 2023 | -6.69M | 3.12M | -6.22M |
---|---|---|---|
Sep 2023 | -4.47M | 10.66M | 78.26K |
Dec 2023 | -3.77M | -3.30M | 30.24K |
Mar 2024 | -5.87M | 2.38M | 0 |
Imunon alternative data
Aug 2023 | 29 |
---|---|
Sep 2023 | 29 |
Oct 2023 | 29 |
Nov 2023 | 29 |
Dec 2023 | 29 |
Jan 2024 | 29 |
Feb 2024 | 29 |
Mar 2024 | 29 |
Apr 2024 | 29 |
May 2024 | 29 |
Jun 2024 | 29 |
Jul 2024 | 29 |
Imunon other data
Period | Buy | Sel |
---|---|---|
May 2021 | 5000 | 0 |
Oct 2021 | 20000 | 0 |
Mar 2022 | 2000 | 0 |
Apr 2022 | 9000 | 0 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Purchase | TARDUGNO MICHAEL H director, officer.. | Celsion Corporation Common Stock | 4,000 | $3.53 | $14,128 | ||
Purchase | TARDUGNO MICHAEL H director, officer.. | Celsion Corporation Common Stock | 4,000 | $3.53 | $14,128 | ||
Purchase | FRITZ FREDERICK J. director | Celsion Corporation Common Stock | 5,000 | $4.05 | $20,250 | ||
Purchase | FRITZ FREDERICK J. director | Celsion Corporation Common Stock | 2,000 | $4.69 | $9,372 | ||
Purchase | FRITZ FREDERICK J. director | Celsion Corporation Common Stock | 20,000 | $0.88 | $17,600 | ||
Purchase | BRAUN DONALD P director | Celsion Corporation Common Stock | 5,000 | $1.07 | $5,350 | ||
Purchase | MARTINEZ ALBERTO R JR director | Celsion Corporation Common Stock | 5,000 | $0.9 | $4,500 | ||
Purchase | MARTINEZ ALBERTO R JR director | Celsion Corporation Common Stock | 6,000 | $1.42 | $8,520 | ||
Purchase | FRITZ FREDERICK J. director | Celsion Corporation Common Stock | 10,000 | $1.39 | $13,880 | ||
Purchase | MARTINEZ ALBERTO R JR director | Celsion Corporation Common Stock | 4,000 | $1.61 | $6,440 |
Quarter | Transcript |
---|---|
Q2 2022 15 Aug 2022 | Q2 2022 Earnings Call Transcript |
Q1 2022 16 May 2022 | Q1 2022 Earnings Call Transcript |
Q4 2021 31 Mar 2022 | Q4 2021 Earnings Call Transcript |
Q3 2021 15 Nov 2021 | Q3 2021 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. Michael H. Tardugno (1951) Executive Chairman, Pres & Chief Executive Officer | $1,000,000 |
Dr. Nicholas Borys (1959) Executive Vice President & Chief Medical Officer | $582,240 |
Mr. Jeffrey W. Church CPA, CPA (1957) Chief Financial Officer, Executive Vice President & Corporation Sec. | $522,620 |
Dr. Khursheed Anwer M.B.A., Ph.D. (1960) Executive Vice President & Chief Scientific Officer | $484,750 |
-
What's the price of Imunon stock today?
One share of Imunon stock can currently be purchased for approximately $1.96.
-
When is Imunon's next earnings date?
Unfortunately, Imunon's (CLSN) next earnings date is currently unknown.
-
Does Imunon pay dividends?
No, Imunon does not pay dividends.
-
How much money does Imunon make?
Imunon has a market capitalization of 14.47M. Imunon made a loss 19.51M US dollars in net income (profit) last year or -$0.87 on an earnings per share basis.
-
What is Imunon's stock symbol?
Imunon, Inc. is traded on the NASDAQ under the ticker symbol "CLSN".
-
What is Imunon's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Imunon?
Shares of Imunon can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Imunon's key executives?
Imunon's management team includes the following people:
- Mr. Michael H. Tardugno Executive Chairman, Pres & Chief Executive Officer(age: 74, pay: $1,000,000)
- Dr. Nicholas Borys Executive Vice President & Chief Medical Officer(age: 66, pay: $582,240)
- Mr. Jeffrey W. Church CPA, CPA Chief Financial Officer, Executive Vice President & Corporation Sec.(age: 68, pay: $522,620)
- Dr. Khursheed Anwer M.B.A., Ph.D. Executive Vice President & Chief Scientific Officer(age: 65, pay: $484,750)
-
How many employees does Imunon have?
As Jul 2024, Imunon employs 29 workers.
-
When Imunon went public?
Imunon, Inc. is publicly traded company for more then 31 years since IPO on 27 Oct 1993.
-
What is Imunon's official website?
The official website for Imunon is celsion.com.
-
Where are Imunon's headquarters?
Imunon is headquartered at 997 Lenox Dr Ste 100, Lawrence Township, NEW JERSEY.
-
How can i contact Imunon?
Imunon's mailing address is 997 Lenox Dr Ste 100, Lawrence Township, NEW JERSEY and company can be reached via phone at +1 609 896 9100.
Imunon company profile:

Imunon, Inc.
celsion.comNASDAQ
29
Biotechnology
Healthcare
Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.
Lawrence Township, NEW JERSEY 08648
CIK: 0000749647
ISIN: US15117N6022
CUSIP: 15117N602